<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0217513</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1037</journal-id>
<journal-id journal-id-type="nlm-ta">Biochim Biophys Acta</journal-id>
<journal-id journal-id-type="iso-abbrev">Biochim. Biophys. Acta</journal-id>
<journal-title-group>
<journal-title>Biochimica et biophysica acta</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3002</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26608610</article-id>
<article-id pub-id-type="pmc">4851888</article-id>
<article-id pub-id-type="doi">10.1016/j.bbamcr.2015.11.016</article-id>
<article-id pub-id-type="manuscript">NIHMS739726</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Calcium-ATPases: Gene Disorders and Dysregulation in Cancer</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dang</surname>
<given-names>Donna</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rao</surname>
<given-names>Rajini</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<aff id="A1">Department of Physiology, The Johns Hopkins University School of Medicine 725 N. Wolfe Street, Baltimore MD 21205, USA</aff>
</contrib-group>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: Phone: +1 (410) 955-4732, <email>rrao@jhmi.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>1863</volume>
<issue>6 Pt B</issue>
<fpage>1344</fpage>
<lpage>1350</lpage>
<!--elocation-id from pubmed: 10.1016/j.bbamcr.2015.11.016-->
<abstract>
<p id="P2">Ca<sup>2+</sup>-ATPases belonging to the superfamily of P-type pumps play an important role in maintaining low, nanomolar cytoplasmic Ca<sup>2+</sup> levels at rest and priming organellar stores, including the endoplasmic reticulum, Golgi and secretory vesicles with high levels of Ca<sup>2+</sup> for a wide range of signaling functions. In this review, we introduce the distinct subtypes of Ca<sup>2+</sup>-ATPases and their isoforms and splice variants, and provide an overview of their specific cellular roles as they relate to genetic disorders and cancer, with a particular emphasis on recent findings on the secretory pathway Ca<sup>2+</sup>-ATPases (SPCA). Mutations in human <italic>ATP2A2</italic>, <italic>ATP2C1</italic> genes, encoding housekeeping isoforms of the endoplasmic reticulum (SERCA2) and secretory pathway (SPCA1) pumps respectively, confer autosomal dominant disorders of the skin, whereas mutations in other isoforms underlie various muscular, neurological or developmental disorders. Emerging evidence points to an important function of dysregulated Ca<sup>2+</sup>-ATPase expression in cancers of the breast, colon, lung and breast where they may serve as markers of differentiation or novel targets for therapeutic intervention. We review the mechanisms underlying the link between calcium homeostasis and cancer and discuss the potential clinical relevance of these observations.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>